Wednesday, June 7, 2023Canada's Leading Online Business Magazine
The Canadian Business Journal The Canadian Business Journal
  • Home
  • Business in Action
    • Recommended
      • 8 Elm Condominium Development – Destined to become a landmark in the heart of Toronto
        8 Elm Condominium Development – Destined to become a landmark in the heart of Toronto
      • The rugged devices that are transforming Canada’s frontline industries
        The rugged devices that are transforming Canada’s frontline industries
        Samsung offers a variety of durable tech solutions to make field work more productive and efficient
      • Samsung Built to Last in Tough Environments
        Samsung Built to Last in Tough Environments
        Ensure your smart devices are better secured and durable to set your organization up for success
      • Browse All Businesses
      • Associations and Unions
      • Agriculture
      • Automotive
      • Communications
      • Construction
      • Education
      • Energy & Resources
      • Finance
      • Food & Beverage
      • Healthcare
      • Manufacturing
      • Municipal
      • Retail
      • Services
      • Sports & Recreation
      • Supply Chain & Logistics
      • Technology
  • Features
    • Recommended Features
      • Skyrocketing Home Prices: When Will it End?
        Skyrocketing Home Prices: When Will it End?
        By Angus Gillespie
      • Mitigating the Pandemic Effects on Future STEM Workforce
        Mitigating the Pandemic Effects on Future STEM Workforce
        By Mary Wells
      • Minimize Taxes By Charitable Donations and Bequests
        Minimize Taxes By Charitable Donations and Bequests
        By Tina Tehranchian
    • Browse by Month
      • Browse All Features
      • August 21
      • May 21
      • Winter 21
      • Nov/Dec 20
      • October 20
      • September 20
      • August 20
  • Be Featured
  • Media Kit
  • Advertise
  • Subscribe
  • Contact
Home | Business News | CBJ Newsmakers | Cotinga Pharmaceuticals Doses First Patient in Third Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

Cotinga Pharmaceuticals Doses First Patient in Third Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

Recommended
  • Medallion Resources Announces Private Placement of Up to CDN$2,000,000 and Debt Settlement of US$650,000Medallion Resources Announces Private Placement of Up to CDN$2,000,000 and Debt Settlement of US$650,000
  • Jade Power Announces First Escrow Release and CVR DistributionĀ and Filing of Q1 2023 Interim Financial StatementsJade Power Announces First Escrow Release and CVR DistributionĀ and Filing of Q1 2023 Interim Financial Statements
  • FLINT to pay interest on Senior Secured Debentures in kindFLINT to pay interest on Senior Secured Debentures in kind
CBJ May 2023 | Volume 16 | Issue 5
Click to View Current Issue
The Canadian Business Journal
Canada's Leading Online Business Magazine
George Media
  • Home
  • Be Featured
  • Advertise with CBJ
  • Contact Us
  • Features
  • Business News
  • CBJ News
  • Editorial
  • Agriculture
  • Automotive
  • Communications
  • Construction
  • Energy & Resources
  • Finance
  • Food & Beverage
  • Manufacturing
  • Associations and Unions
  • Municipal
  • Retail
  • Services
© Copyright 2023 The Canadian Business Journal. George Media Inc. All rights reserved.
DIOS Exploration campaign well underway on K2 gold-copper-silver project
MacDonald Mines Outlines its Summer 2019 Exploration Plans for the Scadding Deposit and the Larger SPJ Project